Welcome to Prof. Thilagar's Research Group

GenoPhe Biotech is officially selected as part of NSRCEL Healthcare Incubation Program (Cohort 3), supported by CSR initiative of DailyRounds / Marrow.

This program will help us advance Chaklz™, our prescription nutraceutical under development for epilepsy management, toward a market-readiness pathway through mentorship, clinical and regulatory exposure, and access to healthcare networks.

Chaklz™ is being developed at GenoPhe based on an exclusive in-licensed intellectual property through IPTeL Office at IISc and scientific discoveries from research led by Upendra Nongthomba and Shefali Mishra at Indian Institute of Science (IISc), in collaboration with Prof. Thilagar, Sambit Pradhan, and James C. (at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)).

We are grateful for this opportunity to learn, validate, and build responsibly — with science, ethics, and the needs of people with epilepsy at the core.